nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—Dermatitis acneiform—Erlotinib—pancreatic cancer	0.0186	0.0282	CcSEcCtD
Fludrocortisone—Cutaneous hypersensitivity—Gemcitabine—pancreatic cancer	0.0181	0.0274	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.0172	0.0505	CbGpPWpGaD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—AGTR1—pancreatic cancer	0.0168	0.0491	CbGpPWpGaD
Fludrocortisone—Cutaneous hypersensitivity—Docetaxel—pancreatic cancer	0.0128	0.0195	CcSEcCtD
Fludrocortisone—Impaired healing—Sunitinib—pancreatic cancer	0.0127	0.0193	CcSEcCtD
Fludrocortisone—Menstruation irregular—Tamoxifen—pancreatic cancer	0.0116	0.0176	CcSEcCtD
Fludrocortisone—Osteoporosis—Tamoxifen—pancreatic cancer	0.0115	0.0174	CcSEcCtD
Fludrocortisone—Multiple fractures—Tamoxifen—pancreatic cancer	0.0111	0.0168	CcSEcCtD
Fludrocortisone—Fracture—Tamoxifen—pancreatic cancer	0.0111	0.0168	CcSEcCtD
Fludrocortisone—Hirsutism—Erlotinib—pancreatic cancer	0.0109	0.0166	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—TFF1—pancreatic cancer	0.0107	0.0315	CbGpPWpGaD
Fludrocortisone—Skin hyperpigmentation—Erlotinib—pancreatic cancer	0.0107	0.0162	CcSEcCtD
Fludrocortisone—Hypernatraemia—Sunitinib—pancreatic cancer	0.0105	0.0159	CcSEcCtD
Fludrocortisone—Optic neuritis—Tamoxifen—pancreatic cancer	0.0104	0.0158	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—NR5A2—pancreatic cancer	0.0101	0.0297	CbGpPWpGaD
Fludrocortisone—Peptic ulcer—Erlotinib—pancreatic cancer	0.00951	0.0144	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Sunitinib—pancreatic cancer	0.00925	0.014	CcSEcCtD
Fludrocortisone—Myopathy—Erlotinib—pancreatic cancer	0.00906	0.0138	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—RBBP8—pancreatic cancer	0.00809	0.0237	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.008	0.0234	CbGpPWpGaD
Fludrocortisone—Myopathy—Sunitinib—pancreatic cancer	0.00784	0.0119	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—NR5A2—pancreatic cancer	0.00768	0.0225	CbGpPWpGaD
Fludrocortisone—Contusion—Tamoxifen—pancreatic cancer	0.00736	0.0112	CcSEcCtD
Fludrocortisone—Amenorrhoea—Tamoxifen—pancreatic cancer	0.00731	0.0111	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BACH1—pancreatic cancer	0.00731	0.0214	CbGpPWpGaD
Fludrocortisone—Skin hyperpigmentation—Fluorouracil—pancreatic cancer	0.0073	0.0111	CcSEcCtD
Fludrocortisone—Cataract—Tamoxifen—pancreatic cancer	0.00675	0.0102	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—PDX1—pancreatic cancer	0.00617	0.0181	CbGpPWpGaD
Fludrocortisone—Fluid retention—Tamoxifen—pancreatic cancer	0.0061	0.00925	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.00607	0.0178	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—HEY2—pancreatic cancer	0.00606	0.0178	CbGpPWpGaD
Fludrocortisone—Dermatitis atopic—Gemcitabine—pancreatic cancer	0.00596	0.00905	CcSEcCtD
Fludrocortisone—Neoplasm—Tamoxifen—pancreatic cancer	0.00581	0.00881	CcSEcCtD
Fludrocortisone—Cardiomegaly—Epirubicin—pancreatic cancer	0.00579	0.00879	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—TGFB1—pancreatic cancer	0.00573	0.0168	CbGpPWpGaD
Fludrocortisone—Menstruation irregular—Docetaxel—pancreatic cancer	0.00566	0.00859	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—HEY1—pancreatic cancer	0.00561	0.0164	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—GDI1—pancreatic cancer	0.00554	0.0162	CbGpPWpGaD
Fludrocortisone—Petechiae—Gemcitabine—pancreatic cancer	0.00536	0.00814	CcSEcCtD
Fludrocortisone—Cardiomegaly—Doxorubicin—pancreatic cancer	0.00536	0.00813	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Docetaxel—pancreatic cancer	0.00527	0.00799	CcSEcCtD
Fludrocortisone—Injury—Tamoxifen—pancreatic cancer	0.00507	0.0077	CcSEcCtD
Fludrocortisone—Oesophagitis—Sunitinib—pancreatic cancer	0.00503	0.00763	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Sunitinib—pancreatic cancer	0.005	0.00759	CcSEcCtD
Fludrocortisone—Neoplasm—Sunitinib—pancreatic cancer	0.00497	0.00755	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—SHH—pancreatic cancer	0.00493	0.0145	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—DAB2—pancreatic cancer	0.00457	0.0134	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—DAXX—pancreatic cancer	0.00444	0.013	CbGpPWpGaD
Fludrocortisone—Mood swings—Tamoxifen—pancreatic cancer	0.00442	0.0067	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Sunitinib—pancreatic cancer	0.0044	0.00668	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Docetaxel—pancreatic cancer	0.00423	0.00642	CcSEcCtD
Fludrocortisone—Fluid retention—Gemcitabine—pancreatic cancer	0.00419	0.00636	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.00418	0.0123	CbGpPWpGaD
Fludrocortisone—Neoplasm—Irinotecan—pancreatic cancer	0.0041	0.00622	CcSEcCtD
Fludrocortisone—Hypernatraemia—Epirubicin—pancreatic cancer	0.00402	0.0061	CcSEcCtD
Fludrocortisone—Oesophagitis—Fluorouracil—pancreatic cancer	0.00397	0.00602	CcSEcCtD
Fludrocortisone—Pancreatitis—Tamoxifen—pancreatic cancer	0.00395	0.006	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Fluorouracil—pancreatic cancer	0.00394	0.00599	CcSEcCtD
Fludrocortisone—Pancreatitis—Erlotinib—pancreatic cancer	0.00391	0.00593	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—SLC2A2—pancreatic cancer	0.00389	0.0114	CbGpPWpGaD
Fludrocortisone—AR—FOXA1 transcription factor network—GCG—pancreatic cancer	0.00381	0.0112	CbGpPWpGaD
Fludrocortisone—Thrombophlebitis—Irinotecan—pancreatic cancer	0.0038	0.00577	CcSEcCtD
Fludrocortisone—Hypernatraemia—Doxorubicin—pancreatic cancer	0.00372	0.00564	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Fluorouracil—pancreatic cancer	0.00364	0.00552	CcSEcCtD
Fludrocortisone—NR3C2—Preimplantation Embryo—CDH1—pancreatic cancer	0.0036	0.0105	CbGpPWpGaD
Fludrocortisone—Injury—Irinotecan—pancreatic cancer	0.00358	0.00543	CcSEcCtD
Fludrocortisone—Amenorrhoea—Docetaxel—pancreatic cancer	0.00356	0.00541	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Epirubicin—pancreatic cancer	0.00355	0.00539	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Gemcitabine—pancreatic cancer	0.00353	0.00536	CcSEcCtD
Fludrocortisone—Muscular weakness—Sunitinib—pancreatic cancer	0.00352	0.00535	CcSEcCtD
Fludrocortisone—Abdominal distension—Sunitinib—pancreatic cancer	0.00347	0.00527	CcSEcCtD
Fludrocortisone—Optic neuritis—Epirubicin—pancreatic cancer	0.00343	0.00521	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Irinotecan—pancreatic cancer	0.0034	0.00516	CcSEcCtD
Fludrocortisone—Pancreatitis—Sunitinib—pancreatic cancer	0.00338	0.00514	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.00332	0.00973	CbGpPWpGaD
Fludrocortisone—Anaphylactoid reaction—Gemcitabine—pancreatic cancer	0.00331	0.00502	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Doxorubicin—pancreatic cancer	0.00329	0.00499	CcSEcCtD
Fludrocortisone—Haemoglobin—Tamoxifen—pancreatic cancer	0.00324	0.00492	CcSEcCtD
Fludrocortisone—Haemorrhage—Tamoxifen—pancreatic cancer	0.00323	0.0049	CcSEcCtD
Fludrocortisone—Haemoglobin—Erlotinib—pancreatic cancer	0.00321	0.00487	CcSEcCtD
Fludrocortisone—Haemorrhage—Erlotinib—pancreatic cancer	0.00319	0.00484	CcSEcCtD
Fludrocortisone—Optic neuritis—Doxorubicin—pancreatic cancer	0.00318	0.00482	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Sunitinib—pancreatic cancer	0.00311	0.00472	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.00298	0.00872	CbGpPWpGaD
Fludrocortisone—Fluid retention—Docetaxel—pancreatic cancer	0.00297	0.00451	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—HES1—pancreatic cancer	0.00291	0.00852	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—pancreatic cancer	0.00288	0.00845	CbGpPWpGaD
Fludrocortisone—Oesophagitis—Docetaxel—pancreatic cancer	0.00286	0.00434	CcSEcCtD
Fludrocortisone—Abdominal distension—Irinotecan—pancreatic cancer	0.00286	0.00434	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Epirubicin—pancreatic cancer	0.00285	0.00433	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.00283	0.00831	CbGpPWpGaD
Fludrocortisone—Neoplasm—Docetaxel—pancreatic cancer	0.00283	0.0043	CcSEcCtD
Fludrocortisone—Erythema—Tamoxifen—pancreatic cancer	0.00281	0.00426	CcSEcCtD
Fludrocortisone—Pancreatitis—Irinotecan—pancreatic cancer	0.00279	0.00423	CcSEcCtD
Fludrocortisone—Muscular weakness—Fluorouracil—pancreatic cancer	0.00278	0.00422	CcSEcCtD
Fludrocortisone—Erythema—Erlotinib—pancreatic cancer	0.00278	0.00422	CcSEcCtD
Fludrocortisone—Haemoglobin—Sunitinib—pancreatic cancer	0.00278	0.00421	CcSEcCtD
Fludrocortisone—Sweating increased—Irinotecan—pancreatic cancer	0.00277	0.0042	CcSEcCtD
Fludrocortisone—Haemorrhage—Sunitinib—pancreatic cancer	0.00276	0.00419	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.00273	0.008	CbGpPWpGaD
Fludrocortisone—Dermatitis atopic—Doxorubicin—pancreatic cancer	0.00264	0.00401	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Docetaxel—pancreatic cancer	0.00263	0.00399	CcSEcCtD
Fludrocortisone—Glycosuria—Epirubicin—pancreatic cancer	0.00261	0.00396	CcSEcCtD
Fludrocortisone—Petechiae—Epirubicin—pancreatic cancer	0.00257	0.0039	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Docetaxel—pancreatic cancer	0.00251	0.00381	CcSEcCtD
Fludrocortisone—NR3C1—Endoderm Differentiation—PTHLH—pancreatic cancer	0.0025	0.00734	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.0025	0.00379	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—PPARG—pancreatic cancer	0.00245	0.00719	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—HIF1A—pancreatic cancer	0.00244	0.00714	CbGpPWpGaD
Fludrocortisone—Hypertension—Tamoxifen—pancreatic cancer	0.00242	0.00368	CcSEcCtD
Fludrocortisone—Glycosuria—Doxorubicin—pancreatic cancer	0.00241	0.00366	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.00241	0.00707	CbGpPWpGaD
Fludrocortisone—Erythema—Sunitinib—pancreatic cancer	0.0024	0.00365	CcSEcCtD
Fludrocortisone—Amenorrhoea—Epirubicin—pancreatic cancer	0.0024	0.00365	CcSEcCtD
Fludrocortisone—Myalgia—Tamoxifen—pancreatic cancer	0.00239	0.00363	CcSEcCtD
Fludrocortisone—Petechiae—Doxorubicin—pancreatic cancer	0.00238	0.00361	CcSEcCtD
Fludrocortisone—Myalgia—Erlotinib—pancreatic cancer	0.00236	0.00359	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—KDR—pancreatic cancer	0.00233	0.00683	CbGpPWpGaD
Fludrocortisone—Oedema—Tamoxifen—pancreatic cancer	0.00229	0.00348	CcSEcCtD
Fludrocortisone—Haemoglobin—Irinotecan—pancreatic cancer	0.00229	0.00347	CcSEcCtD
Fludrocortisone—NR3C1—Endoderm Differentiation—EZH2—pancreatic cancer	0.00228	0.00668	CbGpPWpGaD
Fludrocortisone—Infection—Tamoxifen—pancreatic cancer	0.00228	0.00346	CcSEcCtD
Fludrocortisone—Haemorrhage—Irinotecan—pancreatic cancer	0.00228	0.00345	CcSEcCtD
Fludrocortisone—Oedema—Erlotinib—pancreatic cancer	0.00227	0.00344	CcSEcCtD
Fludrocortisone—Infection—Erlotinib—pancreatic cancer	0.00225	0.00342	CcSEcCtD
Fludrocortisone—Haemoglobin—Gemcitabine—pancreatic cancer	0.00223	0.00338	CcSEcCtD
Fludrocortisone—Amenorrhoea—Doxorubicin—pancreatic cancer	0.00222	0.00338	CcSEcCtD
Fludrocortisone—Haemorrhage—Gemcitabine—pancreatic cancer	0.00222	0.00336	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00222	0.00336	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—NOTCH1—pancreatic cancer	0.00219	0.00643	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Fluorouracil—pancreatic cancer	0.00219	0.00332	CcSEcCtD
Fludrocortisone—Haemorrhage—Fluorouracil—pancreatic cancer	0.00218	0.00331	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.00215	0.0063	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.00215	0.0063	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AHR—pancreatic cancer	0.0021	0.00617	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.00209	0.00317	CcSEcCtD
Fludrocortisone—Convulsion—Sunitinib—pancreatic cancer	0.00208	0.00316	CcSEcCtD
Fludrocortisone—Hypertension—Sunitinib—pancreatic cancer	0.00208	0.00315	CcSEcCtD
Fludrocortisone—Insomnia—Tamoxifen—pancreatic cancer	0.00207	0.00315	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.00207	0.00607	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.00207	0.00313	CcSEcCtD
Fludrocortisone—Insomnia—Erlotinib—pancreatic cancer	0.00205	0.00311	CcSEcCtD
Fludrocortisone—Myalgia—Sunitinib—pancreatic cancer	0.00205	0.00311	CcSEcCtD
Fludrocortisone—Fluid retention—Epirubicin—pancreatic cancer	0.00201	0.00304	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—RB1—pancreatic cancer	0.00198	0.00581	CbGpPWpGaD
Fludrocortisone—Oedema—Sunitinib—pancreatic cancer	0.00196	0.00298	CcSEcCtD
Fludrocortisone—Infection—Sunitinib—pancreatic cancer	0.00195	0.00296	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.00194	0.00569	CbGpPWpGaD
Fludrocortisone—Oesophagitis—Epirubicin—pancreatic cancer	0.00193	0.00293	CcSEcCtD
Fludrocortisone—Erythema—Gemcitabine—pancreatic cancer	0.00193	0.00293	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—SMAD4—pancreatic cancer	0.00193	0.00564	CbGpPWpGaD
Fludrocortisone—Rash maculo-papular—Epirubicin—pancreatic cancer	0.00192	0.00291	CcSEcCtD
Fludrocortisone—Neoplasm—Epirubicin—pancreatic cancer	0.00191	0.0029	CcSEcCtD
Fludrocortisone—Ecchymosis—Epirubicin—pancreatic cancer	0.00191	0.0029	CcSEcCtD
Fludrocortisone—Erythema—Fluorouracil—pancreatic cancer	0.0019	0.00288	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—PPARG—pancreatic cancer	0.00186	0.00546	CbGpPWpGaD
Fludrocortisone—Fluid retention—Doxorubicin—pancreatic cancer	0.00186	0.00282	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—SRC—pancreatic cancer	0.00184	0.00539	CbGpPWpGaD
Fludrocortisone—Urticaria—Tamoxifen—pancreatic cancer	0.00182	0.00276	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—AHR—pancreatic cancer	0.0018	0.00527	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00179	0.00271	CcSEcCtD
Fludrocortisone—Oesophagitis—Doxorubicin—pancreatic cancer	0.00179	0.00271	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—SMAD4—pancreatic cancer	0.00179	0.00523	CbGpPWpGaD
Fludrocortisone—Vertigo—Irinotecan—pancreatic cancer	0.00178	0.0027	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Doxorubicin—pancreatic cancer	0.00178	0.0027	CcSEcCtD
Fludrocortisone—Insomnia—Sunitinib—pancreatic cancer	0.00177	0.00269	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Epirubicin—pancreatic cancer	0.00177	0.00269	CcSEcCtD
Fludrocortisone—Ecchymosis—Doxorubicin—pancreatic cancer	0.00177	0.00268	CcSEcCtD
Fludrocortisone—Neoplasm—Doxorubicin—pancreatic cancer	0.00177	0.00268	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Epirubicin—pancreatic cancer	0.00176	0.00268	CcSEcCtD
Fludrocortisone—Vascular purpura—Epirubicin—pancreatic cancer	0.00171	0.0026	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—CHD3—pancreatic cancer	0.00171	0.00501	CbGpPWpGaD
Fludrocortisone—Hypertension—Irinotecan—pancreatic cancer	0.00171	0.0026	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MEN1—pancreatic cancer	0.00171	0.00501	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.0017	0.00498	CbGpPWpGaD
Fludrocortisone—Cardiac failure congestive—Epirubicin—pancreatic cancer	0.00169	0.00257	CcSEcCtD
Fludrocortisone—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00169	0.00256	CcSEcCtD
Fludrocortisone—NR3C1—Endoderm Differentiation—SMAD4—pancreatic cancer	0.00168	0.00493	CbGpPWpGaD
Fludrocortisone—Hypertension—Gemcitabine—pancreatic cancer	0.00167	0.00253	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—pancreatic cancer	0.00166	0.00488	CbGpPWpGaD
Fludrocortisone—Asthenia—Tamoxifen—pancreatic cancer	0.00164	0.0025	CcSEcCtD
Fludrocortisone—Convulsion—Fluorouracil—pancreatic cancer	0.00164	0.00249	CcSEcCtD
Fludrocortisone—Myalgia—Gemcitabine—pancreatic cancer	0.00164	0.00249	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Doxorubicin—pancreatic cancer	0.00164	0.00249	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Doxorubicin—pancreatic cancer	0.00163	0.00248	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.00163	0.00478	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—HIF1A—pancreatic cancer	0.00163	0.00478	CbGpPWpGaD
Fludrocortisone—Asthenia—Erlotinib—pancreatic cancer	0.00163	0.00247	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.00162	0.00475	CbGpPWpGaD
Fludrocortisone—Oedema—Irinotecan—pancreatic cancer	0.00162	0.00245	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00162	0.00245	CcSEcCtD
Fludrocortisone—Myalgia—Fluorouracil—pancreatic cancer	0.00162	0.00245	CcSEcCtD
Fludrocortisone—Infection—Irinotecan—pancreatic cancer	0.00161	0.00244	CcSEcCtD
Fludrocortisone—Purpura—Epirubicin—pancreatic cancer	0.00159	0.00241	CcSEcCtD
Fludrocortisone—Vascular purpura—Doxorubicin—pancreatic cancer	0.00159	0.00241	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00158	0.0024	CcSEcCtD
Fludrocortisone—Haemoglobin—Docetaxel—pancreatic cancer	0.00158	0.0024	CcSEcCtD
Fludrocortisone—Oedema—Gemcitabine—pancreatic cancer	0.00157	0.00239	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00157	0.00239	CcSEcCtD
Fludrocortisone—Haemorrhage—Docetaxel—pancreatic cancer	0.00157	0.00239	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.00156	0.00237	CcSEcCtD
Fludrocortisone—Infection—Gemcitabine—pancreatic cancer	0.00156	0.00237	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00156	0.00237	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—GADD45A—pancreatic cancer	0.00156	0.00457	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.00155	0.00455	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00155	0.00235	CcSEcCtD
Fludrocortisone—Oedema—Fluorouracil—pancreatic cancer	0.00155	0.00235	CcSEcCtD
Fludrocortisone—Infection—Fluorouracil—pancreatic cancer	0.00154	0.00233	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—pancreatic cancer	0.00153	0.00449	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.00152	0.00447	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00152	0.00231	CcSEcCtD
Fludrocortisone—Affect lability—Epirubicin—pancreatic cancer	0.00151	0.00229	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.0015	0.00441	CbGpPWpGaD
Fludrocortisone—Purpura—Doxorubicin—pancreatic cancer	0.00147	0.00223	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.00147	0.00431	CbGpPWpGaD
Fludrocortisone—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00147	0.00223	CcSEcCtD
Fludrocortisone—Insomnia—Irinotecan—pancreatic cancer	0.00146	0.00222	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—pancreatic cancer	0.00146	0.00428	CbGpPWpGaD
Fludrocortisone—Mood swings—Epirubicin—pancreatic cancer	0.00145	0.00221	CcSEcCtD
Fludrocortisone—Hypersensitivity—Sunitinib—pancreatic cancer	0.00145	0.00219	CcSEcCtD
Fludrocortisone—Headache—Tamoxifen—pancreatic cancer	0.00144	0.00218	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00143	0.00218	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—NR5A2—pancreatic cancer	0.00143	0.0042	CbGpPWpGaD
Fludrocortisone—Insomnia—Gemcitabine—pancreatic cancer	0.00142	0.00216	CcSEcCtD
Fludrocortisone—Headache—Erlotinib—pancreatic cancer	0.00142	0.00216	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CDKN2A—pancreatic cancer	0.00141	0.00415	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00141	0.00214	CcSEcCtD
Fludrocortisone—Asthenia—Sunitinib—pancreatic cancer	0.00141	0.00214	CcSEcCtD
Fludrocortisone—Insomnia—Fluorouracil—pancreatic cancer	0.0014	0.00213	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—PIK3CA—pancreatic cancer	0.0014	0.0041	CbGpPWpGaD
Fludrocortisone—Affect lability—Doxorubicin—pancreatic cancer	0.0014	0.00212	CcSEcCtD
Fludrocortisone—AR—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.00138	0.00405	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.00138	0.00404	CbGpPWpGaD
Fludrocortisone—Erythema—Docetaxel—pancreatic cancer	0.00137	0.00208	CcSEcCtD
Fludrocortisone—Muscular weakness—Epirubicin—pancreatic cancer	0.00135	0.00205	CcSEcCtD
Fludrocortisone—Mood swings—Doxorubicin—pancreatic cancer	0.00134	0.00204	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—HIF1A—pancreatic cancer	0.00134	0.00394	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—STK11—pancreatic cancer	0.00134	0.00392	CbGpPWpGaD
Fludrocortisone—Abdominal distension—Epirubicin—pancreatic cancer	0.00133	0.00203	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—GADD45A—pancreatic cancer	0.00133	0.00391	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—PLAU—pancreatic cancer	0.00133	0.0039	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.00132	0.00385	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Epirubicin—pancreatic cancer	0.0013	0.00197	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—HRAS—pancreatic cancer	0.00129	0.00379	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.00129	0.00379	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—pancreatic cancer	0.00129	0.00378	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—STAT3—pancreatic cancer	0.00127	0.00372	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Doxorubicin—pancreatic cancer	0.00125	0.0019	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—pancreatic cancer	0.00124	0.00364	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—NOTCH1—pancreatic cancer	0.00124	0.00363	CbGpPWpGaD
Fludrocortisone—Abdominal distension—Doxorubicin—pancreatic cancer	0.00123	0.00187	CcSEcCtD
Fludrocortisone—Urticaria—Fluorouracil—pancreatic cancer	0.00123	0.00187	CcSEcCtD
Fludrocortisone—Headache—Sunitinib—pancreatic cancer	0.00123	0.00187	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BRCA2—pancreatic cancer	0.00121	0.00354	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Doxorubicin—pancreatic cancer	0.0012	0.00183	CcSEcCtD
Fludrocortisone—AR—Regulation of Androgen receptor activity—SRC—pancreatic cancer	0.0012	0.00351	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Epirubicin—pancreatic cancer	0.0012	0.00181	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CCND1—pancreatic cancer	0.00119	0.0035	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Irinotecan—pancreatic cancer	0.00119	0.00181	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—RB1—pancreatic cancer	0.00119	0.00349	CbGpPWpGaD
Fludrocortisone—Convulsion—Docetaxel—pancreatic cancer	0.00119	0.0018	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CTNNB1—pancreatic cancer	0.00118	0.00347	CbGpPWpGaD
Fludrocortisone—Hypertension—Docetaxel—pancreatic cancer	0.00118	0.00179	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.00118	0.00345	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—SMAD4—pancreatic cancer	0.00117	0.00343	CbGpPWpGaD
Fludrocortisone—Myalgia—Docetaxel—pancreatic cancer	0.00117	0.00177	CcSEcCtD
Fludrocortisone—Asthenia—Irinotecan—pancreatic cancer	0.00116	0.00176	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—AKT1—pancreatic cancer	0.00114	0.00335	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00114	0.00173	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—pancreatic cancer	0.00114	0.00334	CbGpPWpGaD
Fludrocortisone—Asthenia—Gemcitabine—pancreatic cancer	0.00113	0.00171	CcSEcCtD
Fludrocortisone—Oedema—Docetaxel—pancreatic cancer	0.00112	0.0017	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00112	0.0017	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.00111	0.00326	CbGpPWpGaD
Fludrocortisone—Infection—Docetaxel—pancreatic cancer	0.00111	0.00169	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.00111	0.00324	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.00111	0.00168	CcSEcCtD
Fludrocortisone—Haemoglobin—Epirubicin—pancreatic cancer	0.00107	0.00162	CcSEcCtD
Fludrocortisone—Haemorrhage—Epirubicin—pancreatic cancer	0.00106	0.00161	CcSEcCtD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.00105	0.00307	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.00104	0.00304	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—pancreatic cancer	0.00103	0.00303	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00102	0.00155	CcSEcCtD
Fludrocortisone—Headache—Irinotecan—pancreatic cancer	0.00101	0.00154	CcSEcCtD
Fludrocortisone—Insomnia—Docetaxel—pancreatic cancer	0.00101	0.00153	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.001	0.00293	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Doxorubicin—pancreatic cancer	0.000987	0.0015	CcSEcCtD
Fludrocortisone—Headache—Gemcitabine—pancreatic cancer	0.000986	0.0015	CcSEcCtD
Fludrocortisone—Haemorrhage—Doxorubicin—pancreatic cancer	0.000982	0.00149	CcSEcCtD
Fludrocortisone—Headache—Fluorouracil—pancreatic cancer	0.00097	0.00147	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000969	0.00284	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—pancreatic cancer	0.000962	0.00282	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN2A—pancreatic cancer	0.000961	0.00282	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TSC2—pancreatic cancer	0.000955	0.0028	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—pancreatic cancer	0.000952	0.00279	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.000952	0.00279	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—pancreatic cancer	0.000934	0.00274	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.000933	0.00273	CbGpPWpGaD
Fludrocortisone—Erythema—Epirubicin—pancreatic cancer	0.000924	0.0014	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—SRC—pancreatic cancer	0.000908	0.00266	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CCND1—pancreatic cancer	0.000883	0.00259	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CTNNB1—pancreatic cancer	0.000875	0.00256	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CXCL8—pancreatic cancer	0.000871	0.00255	CbGpPWpGaD
Fludrocortisone—Erythema—Doxorubicin—pancreatic cancer	0.000855	0.0013	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—PTEN—pancreatic cancer	0.000852	0.0025	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.000844	0.00248	CbGpPWpGaD
Fludrocortisone—Vertigo—Epirubicin—pancreatic cancer	0.00083	0.00126	CcSEcCtD
Fludrocortisone—Hypersensitivity—Docetaxel—pancreatic cancer	0.000823	0.00125	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—MEN1—pancreatic cancer	0.000823	0.00241	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—CTNNB1—pancreatic cancer	0.000823	0.00241	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—HIF1A—pancreatic cancer	0.000819	0.0024	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCND1—pancreatic cancer	0.000812	0.00238	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CTNNB1—pancreatic cancer	0.000804	0.00236	CbGpPWpGaD
Fludrocortisone—Asthenia—Docetaxel—pancreatic cancer	0.000802	0.00122	CcSEcCtD
Fludrocortisone—Convulsion—Epirubicin—pancreatic cancer	0.0008	0.00121	CcSEcCtD
Fludrocortisone—Hypertension—Epirubicin—pancreatic cancer	0.000797	0.00121	CcSEcCtD
Fludrocortisone—AR—Gene Expression—CHD3—pancreatic cancer	0.000794	0.00233	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000793	0.00233	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—SRC—pancreatic cancer	0.00079	0.00232	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP9—pancreatic cancer	0.000788	0.00231	CbGpPWpGaD
Fludrocortisone—Myalgia—Epirubicin—pancreatic cancer	0.000786	0.00119	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—PTEN—pancreatic cancer	0.000784	0.0023	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NOTCH4—pancreatic cancer	0.00078	0.00229	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	0.000779	0.00228	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	0.000776	0.00228	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—pancreatic cancer	0.000771	0.00226	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—pancreatic cancer	0.000768	0.00225	CbGpPWpGaD
Fludrocortisone—Vertigo—Doxorubicin—pancreatic cancer	0.000768	0.00117	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000765	0.00224	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	0.000764	0.00224	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—STAT3—pancreatic cancer	0.000762	0.00223	CbGpPWpGaD
Fludrocortisone—Oedema—Epirubicin—pancreatic cancer	0.000754	0.00114	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000754	0.00114	CcSEcCtD
Fludrocortisone—AR—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000752	0.0022	CbGpPWpGaD
Fludrocortisone—Infection—Epirubicin—pancreatic cancer	0.000749	0.00114	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—HSPA1B—pancreatic cancer	0.000744	0.00218	CbGpPWpGaD
Fludrocortisone—Convulsion—Doxorubicin—pancreatic cancer	0.00074	0.00112	CcSEcCtD
Fludrocortisone—Hypertension—Doxorubicin—pancreatic cancer	0.000738	0.00112	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000729	0.00111	CcSEcCtD
Fludrocortisone—Myalgia—Doxorubicin—pancreatic cancer	0.000728	0.0011	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000722	0.00212	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000722	0.00212	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.000708	0.00207	CbGpPWpGaD
Fludrocortisone—Headache—Docetaxel—pancreatic cancer	0.0007	0.00106	CcSEcCtD
Fludrocortisone—Oedema—Doxorubicin—pancreatic cancer	0.000697	0.00106	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000697	0.00106	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—PPARG—pancreatic cancer	0.000696	0.00204	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—EGFR—pancreatic cancer	0.000693	0.00203	CbGpPWpGaD
Fludrocortisone—Infection—Doxorubicin—pancreatic cancer	0.000693	0.00105	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000691	0.00202	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000687	0.00104	CcSEcCtD
Fludrocortisone—Insomnia—Epirubicin—pancreatic cancer	0.000682	0.00103	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—EZH2—pancreatic cancer	0.000678	0.00199	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000674	0.00102	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—RB1—pancreatic cancer	0.000666	0.00195	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NR5A2—pancreatic cancer	0.000665	0.00195	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—TGFB1—pancreatic cancer	0.000665	0.00195	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—AKT1—pancreatic cancer	0.000665	0.00195	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NOTCH3—pancreatic cancer	0.000663	0.00194	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	0.000655	0.00192	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MYC—pancreatic cancer	0.000651	0.00191	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TGFB1—pancreatic cancer	0.00065	0.0019	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000639	0.00187	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000635	0.000964	CcSEcCtD
Fludrocortisone—Insomnia—Doxorubicin—pancreatic cancer	0.000631	0.000957	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—HSPA1A—pancreatic cancer	0.000628	0.00184	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.000605	0.00177	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CHD3—pancreatic cancer	0.000602	0.00176	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000602	0.00176	CbGpPWpGaD
Fludrocortisone—Urticaria—Epirubicin—pancreatic cancer	0.000599	0.000909	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	0.000594	0.00174	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	0.000579	0.0017	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.000579	0.0017	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	0.000579	0.0017	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	0.000573	0.00168	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000571	0.00167	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	0.000558	0.00164	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000558	0.00164	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Epirubicin—pancreatic cancer	0.000555	0.000843	CcSEcCtD
Fludrocortisone—Urticaria—Doxorubicin—pancreatic cancer	0.000554	0.000841	CcSEcCtD
Fludrocortisone—Asthenia—Epirubicin—pancreatic cancer	0.000541	0.000821	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—pancreatic cancer	0.000535	0.00157	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000531	0.00156	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	0.00053	0.00155	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000514	0.00078	CcSEcCtD
Fludrocortisone—NR3C1—Gene Expression—NR5A2—pancreatic cancer	0.000504	0.00148	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	0.000504	0.00148	CbGpPWpGaD
Fludrocortisone—Asthenia—Doxorubicin—pancreatic cancer	0.0005	0.000759	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—SMAD4—pancreatic cancer	0.0005	0.00146	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000493	0.00144	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000491	0.00144	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—AKT1—pancreatic cancer	0.000491	0.00144	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—CTNNB1—pancreatic cancer	0.00049	0.00144	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000485	0.00142	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000482	0.00141	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000479	0.00141	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000475	0.00139	CbGpPWpGaD
Fludrocortisone—Headache—Epirubicin—pancreatic cancer	0.000472	0.000717	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—pancreatic cancer	0.000471	0.00138	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	0.000464	0.00136	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000463	0.00136	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.000459	0.00135	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	0.000454	0.00133	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.000439	0.00129	CbGpPWpGaD
Fludrocortisone—Headache—Doxorubicin—pancreatic cancer	0.000437	0.000663	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.000429	0.00126	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	0.000429	0.00126	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—STAT3—pancreatic cancer	0.000427	0.00125	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000423	0.00124	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000421	0.00123	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.000418	0.00123	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MYC—pancreatic cancer	0.000412	0.00121	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	0.000402	0.00118	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—pancreatic cancer	0.000398	0.00117	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TGFB1—pancreatic cancer	0.000396	0.00116	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000385	0.00113	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.000384	0.00112	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MEN1—pancreatic cancer	0.000382	0.00112	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	0.000381	0.00112	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.000376	0.0011	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000373	0.00109	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TNF—pancreatic cancer	0.00037	0.00108	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NOTCH1—pancreatic cancer	0.000368	0.00108	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000365	0.00107	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NOTCH4—pancreatic cancer	0.000362	0.00106	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000358	0.00105	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.000355	0.00104	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000355	0.00104	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PPARG—pancreatic cancer	0.000348	0.00102	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HSPA1B—pancreatic cancer	0.000345	0.00101	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000335	0.000982	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000326	0.000957	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	0.000322	0.000943	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.00032	0.000937	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000316	0.000926	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—EZH2—pancreatic cancer	0.000315	0.000922	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NOTCH3—pancreatic cancer	0.000308	0.000902	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HSPA1A—pancreatic cancer	0.000292	0.000855	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MEN1—pancreatic cancer	0.00029	0.000849	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NOTCH4—pancreatic cancer	0.000275	0.000805	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000269	0.000789	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.000267	0.000782	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HSPA1B—pancreatic cancer	0.000262	0.000768	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000254	0.000745	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—EZH2—pancreatic cancer	0.000239	0.000699	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NOTCH3—pancreatic cancer	0.000234	0.000685	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SMAD4—pancreatic cancer	0.000232	0.00068	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HSPA1A—pancreatic cancer	0.000221	0.000648	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MYC—pancreatic cancer	0.000198	0.000581	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MYC—pancreatic cancer	0.000191	0.00056	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SMAD4—pancreatic cancer	0.000176	0.000516	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NOTCH1—pancreatic cancer	0.000171	0.000501	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARG—pancreatic cancer	0.000161	0.000473	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MYC—pancreatic cancer	0.000145	0.000425	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AKT1—pancreatic cancer	0.000137	0.000403	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NOTCH1—pancreatic cancer	0.00013	0.00038	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARG—pancreatic cancer	0.000122	0.000359	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MYC—pancreatic cancer	9.2e-05	0.00027	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MYC—pancreatic cancer	6.98e-05	0.000205	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—AKT1—pancreatic cancer	6.38e-05	0.000187	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AKT1—pancreatic cancer	4.84e-05	0.000142	CbGpPWpGaD
